Rapid, near patient cardiac Troponin test to rule in or rule out NSTEMI

Rapid, near patient
cardiac Troponin test to
rule in or rule out NSTEMI  

Acute Coronary Syndrome (ACS) presents a significant mortality risk and it is essential to rule in or rule out non ST-segment elevation myocardial infarction (NSTEMI) as soon as possible. You need accurate test results quickly so that you can decide what intervention is best for your patient. A delay in diagnosis can cause anxiety for patients and their families and increases pressure on an over-crowded emergency department.

Contact us

Contact information

* This field is mandatory

Contact details

*
*
*

Company details

*
*
*
*
*
*
*

Business details

By specifying your reason for contact we will be able to provide you with a better service.
*
*
*
Lab comparable results within 10 minutes

Lab comparable results within 10 minutes

 

What if you could run that critical Troponin test close to the patient on arrival in the emergency department, from just a finger prick of blood – and have lab comparable results in front of you within 10 minutes? You could then make a potentially life-saving decision on the spot.

Point-of-care testing (POCT) can significantly reduce turnaround time for a cardiac Troponin test result
Quotation mark

Point-of-care testing (POCT) can significantly reduce turnaround time for a cardiac Troponin test result.”

 

Chris Price, Visiting Professor in Clinical Biochemistry, Nuffield Department of Primary Care Health Sciences, University of Oxford'

When time counts, point-of-care blood testing speeds acute care decisions

When time counts, point-of-care blood testing speeds acute care decisions

Philips cardiovascular diagnostic tools already provide powerful solutions for the diagnosis and management of heart diseases. In the acute setting, the ECG system identifies life-threatening ST segment elevation myocardial infarction (STEMI). But for most patients with suspicion of ACS and no persistent ST-elevation, you will need to measure cardiac markers, preferably troponin. Yet it can take over an hour to get the results back from the lab. Minicare I-20* acute point-of-care testing reduces this turnaround time.
Diagnostic accuracy from just a finger prick of blood

Diagnostic accuracy from just a finger prick of blood

Philips is developing the Minicare I-20 acute care, in-vitro diagnostics system to give you the clinical information you need, from just a finger prick of blood. Having access to robust, accurate near-patient testing like this makes it possible to measure your patient’s troponin levels while you are assessing them in the emergency department.

 

This helps you provide patients with the best possible care. You can more quickly identify those who need your urgent attention, helping to reduce their anxiety if a acute cardiac condition is suspected.

Faster diagnosis to reduce overcrowding and improve workflow

Faster diagnosis to reduce overcrowding and improve workflow

With blood test results available in the emergency department within minutes, you will have the confidence to make vital decisions without delay. It may be easier to discharge some patients more quickly, while ensuring others receive early, potentially lifesaving treatment.

 

Delivering faster results not only benefits your patients. This could make a significant impact on the efficient running of the department. Reducing overcrowding could mean fewer delays in meeting turnaround time targets. And if you are able to increase operational efficiency, then your own stress and that of your team would be less.

Quotation mark

Workflow pressures and waiting times are major causes of stress to ED teams”

 

Professor Roland Bingisser of the University Hospital, Basel, Switzerland

* Product available in selected countries only. Check with your local Philips representative for availability.